The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.
Published: April 16, 2019 at 02:00AM
from NYT Health https://nyti.ms/2GlsXBT
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.
Published: April 16, 2019 at 02:00AM
from NYT Health https://nyti.ms/2GlsXBT